GERN
Geron Corp
Price:  
1.51 
USD
Volume:  
10,757,634.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-280.5%
Upside

As of 2025-06-22, the EV/EBITDA ratio of Geron Corp (GERN) is -7.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 996.73 mil USD. GERN's TTM EBITDA according to its financial statements is -133.14 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.0x - 11.9x 10.0x
Forward P/E multiples 11.0x - 20.2x 15.6x
Fair Price (2.35) - (2.54) (2.73)
Upside -255.9% - -268.4% -280.5%
1.51 USD
Stock Price
(2.73) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-20 -7.49
2025-06-18 -7.68
2025-06-17 -7.20
2025-06-16 -7.68
2025-06-13 -7.49
2025-06-12 -7.73
2025-06-11 -7.63
2025-06-10 -7.92
2025-06-09 -8.01
2025-06-06 -7.92
2025-06-05 -7.73
2025-06-04 -7.63
2025-06-03 -7.77
2025-06-02 -7.10
2025-05-30 -7.53
2025-05-29 -7.34
2025-05-28 -7.20
2025-05-27 -7.39
2025-05-23 -7.20
2025-05-22 -7.34
2025-05-21 -6.67
2025-05-20 -6.91
2025-05-19 -6.91
2025-05-16 -6.34
2025-05-15 -6.05
2025-05-14 -5.96
2025-05-13 -6.00
2025-05-12 -6.39
2025-05-09 -5.91
2025-05-08 -6.29
2025-05-07 -6.53
2025-05-06 -6.58
2025-05-05 -7.06
2025-05-02 -6.86
2025-05-01 -7.10
2025-04-30 -7.01
2025-04-29 -6.86
2025-04-28 -6.96
2025-04-25 -7.06
2025-04-24 -7.06
2025-04-23 -6.91
2025-04-22 -7.01
2025-04-21 -6.72
2025-04-17 -6.34
2025-04-16 -6.19
2025-04-15 -6.24
2025-04-14 -6.58
2025-04-11 -6.86
2025-04-10 -6.48
2025-04-09 -6.91